INVO Bioscience Inc
NASDAQ:INVO
INVO Bioscience Inc
NASDAQ:INVO
Price:
0.78 USD
1.3%
Market Closed
Updated:
Jun 8, 2024
INVO Bioscience Inc
Current Portion of Long-Term Debt
|
INVO Bioscience Inc
Current Portion of Long-Term Debt Peer Comparison
Comparables:
BSX
SYK
ABT
ISRG
SWAV
Competitive Current Portion of Long-Term Debt Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Current Portion of Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
INVO Bioscience Inc
NASDAQ:INVO
|
Current Portion of Long-Term Debt
$795.8k
|
CAGR 3-Years
33%
|
CAGR 5-Years
140%
|
CAGR 10-Years
N/A
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Current Portion of Long-Term Debt
$1.1B
|
CAGR 3-Years
337%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
75%
|
|
|
Stryker Corp
NYSE:SYK
|
Current Portion of Long-Term Debt
$2.1B
|
CAGR 3-Years
416%
|
CAGR 5-Years
32%
|
CAGR 10-Years
10%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Current Portion of Long-Term Debt
$2B
|
CAGR 3-Years
39%
|
CAGR 5-Years
202%
|
CAGR 10-Years
74%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Current Portion of Long-Term Debt
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Shockwave Medical Inc
NASDAQ:SWAV
|
Current Portion of Long-Term Debt
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is INVO Bioscience Inc's Current Portion of Long-Term Debt?
Current Portion of Long-Term Debt
795.8k
USD
795.8k
USD
Based on the financial report for Mar 31, 2024, INVO Bioscience Inc's Current Portion of Long-Term Debt amounts to 795.8k USD.
What is INVO Bioscience Inc's Current Portion of Long-Term Debt growth rate?
Current Portion of Long-Term Debt CAGR 5Y
140%
140%
Over the last year, the Current Portion of Long-Term Debt growth was 141%. The average annual Current Portion of Long-Term Debt growth rates for INVO Bioscience Inc have been 33% over the past three years , 140% over the past five years .
You don't have any saved screeners yet
